These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 12870812)
21. Epoxycyclohexenedione-Type Compounds Make Up a New Class of Inhibitors of the Bovine Mitochondrial ADP/ATP Carrier. Aoyama A; Murai M; Ichimaru N; Aburaya S; Aoki W; Miyoshi H Biochemistry; 2018 Feb; 57(6):1031-1044. PubMed ID: 29313673 [TBL] [Abstract][Full Text] [Related]
22. Fumagalone, a reversible inhibitor of type 2 methionine aminopeptidase and angiogenesis. Zhou G; Tsai CW; Liu JO J Med Chem; 2003 Jul; 46(16):3452-4. PubMed ID: 12877582 [TBL] [Abstract][Full Text] [Related]
23. Novel cyclopentanone derivatives pentenocins A and B with interleukin-1beta converting enzyme inhibitory activity, produced by Trichoderma hamatum FO-6903. Matsumoto T; Ishiyama A; Yamaguchi Y; Masuma R; Ui H; Shiomi K; Yamada H; Omura S J Antibiot (Tokyo); 1999 Aug; 52(8):754-7. PubMed ID: 10580389 [No Abstract] [Full Text] [Related]
25. HIV-1 coat protein gp120 stimulates interleukin-1beta secretion from human neuroblastoma cells: evidence for a role in the mechanism of cell death. Corasaniti MT; Bilotta A; Strongoli MC; Navarra M; Bagetta G; Di Renzo G Br J Pharmacol; 2001 Nov; 134(6):1344-50. PubMed ID: 11704656 [TBL] [Abstract][Full Text] [Related]
26. Enzymatic activity of two caspases related to interleukin-1beta-converting enzyme. Fassy F; Krebs O; Rey H; Komara B; Gillard C; Capdevila C; Yea C; Faucheu C; Blanchet AM; Miossec C; Diu-Hercend A Eur J Biochem; 1998 Apr; 253(1):76-83. PubMed ID: 9578463 [TBL] [Abstract][Full Text] [Related]
27. Effects of specific interleukin-1beta-converting enzyme inhibitor on ischemic acute renal failure in murine models. Liu HF; Liang D; Wang LM; Zhou N; Yao CW; Hong T; Tang DS; Chen XW Acta Pharmacol Sin; 2005 Nov; 26(11):1345-51. PubMed ID: 16225757 [TBL] [Abstract][Full Text] [Related]
28. Stereoselective total synthesis of ent-EI-1941-2 and Epi-ent-EI-1941-2. Shoji M; Uno T; Hayashi Y Org Lett; 2004 Nov; 6(24):4535-8. PubMed ID: 15548069 [TBL] [Abstract][Full Text] [Related]
29. Reversal of antisecretory activity of omeprazole by sulfhydryl compounds in isolated rabbit gastric glands. Im WB; Blakeman DP; Sachs G Biochim Biophys Acta; 1985 Apr; 845(1):54-9. PubMed ID: 3978129 [TBL] [Abstract][Full Text] [Related]
30. Distinct interleukin-1beta-converting enzyme family proteases mediate cisplatin- and staurosporine-induced apoptosis of mouse proximal tubule cells. Fukuoka K; Takeda M; Kobayashi M; Osaki T; Shirato I; Soejima A; Nagasawa T; Endou H Life Sci; 1998; 62(12):1125-38. PubMed ID: 9519815 [TBL] [Abstract][Full Text] [Related]
31. Aggregatibacter actinomycetemcomitans Invasion Induces Interleukin-1β Production Through Reactive Oxygen Species and Cathepsin B. Okinaga T; Ariyoshi W; Nishihara T J Interferon Cytokine Res; 2015 Jun; 35(6):431-40. PubMed ID: 25789553 [TBL] [Abstract][Full Text] [Related]
32. Metabolites with nematicidal and antimicrobial activities from the ascomycete Lachnum papyraceum (Karst.) Karst. V. Production, isolation and biological activities of bromine-containing mycorrhizin and lachnumon derivatives and four additional new bioactive metabolites. Stadler M; Anke H; Sterner O J Antibiot (Tokyo); 1995 Feb; 48(2):149-53. PubMed ID: 7706125 [TBL] [Abstract][Full Text] [Related]
34. Activation of interleukin-1beta-converting enzyme by nigericin is independent of apoptosis. Watanabe N; Kawaguchi M; Kobayashi Y Cytokine; 1998 Sep; 10(9):645-53. PubMed ID: 9770325 [TBL] [Abstract][Full Text] [Related]
35. Temporal profile of release of interleukin-1beta in neurotrauma. Fassbender K; Schneider S; Bertsch T; Schlueter D; Fatar M; Ragoschke A; Kühl S; Kischka U; Hennerici M Neurosci Lett; 2000 Apr; 284(3):135-8. PubMed ID: 10773417 [TBL] [Abstract][Full Text] [Related]
36. (±) cis-Bisamido epoxides: A novel series of potent FXIII-A inhibitors. Avery CA; Pease RJ; Smith K; Boothby M; Buckley HM; Grant PJ; Fishwick CW Eur J Med Chem; 2015 Jun; 98():49-53. PubMed ID: 26005023 [TBL] [Abstract][Full Text] [Related]
37. IL-1 beta converting enzyme is a target for nitric oxide-releasing aspirin: new insights in the antiinflammatory mechanism of nitric oxide-releasing nonsteroidal antiinflammatory drugs. Fiorucci S; Santucci L; Cirino G; Mencarelli A; Familiari L; Soldato PD; Morelli A J Immunol; 2000 Nov; 165(9):5245-54. PubMed ID: 11046058 [TBL] [Abstract][Full Text] [Related]
38. Novel epicatechin derivatives with antioxidant activity modulate interleukin-1beta release in lipopolysaccharide-stimulated human blood. Mitjans M; Martínez V; del Campo J; Abajo C; Lozano C; Torres JL; Vinardell MP Bioorg Med Chem Lett; 2004 Oct; 14(20):5031-4. PubMed ID: 15380193 [TBL] [Abstract][Full Text] [Related]
39. 4-Hydroxynonenal inhibits interleukin-1 beta converting enzyme. Davis DW; Hamilton RF; Holian A J Interferon Cytokine Res; 1997 Apr; 17(4):205-10. PubMed ID: 9142649 [TBL] [Abstract][Full Text] [Related]
40. In vitro effects of aceclofenac and its metabolites on the production by chondrocytes of inflammatory mediators. Henrotin Y; de Leval X; Mathy-Hartet M; Mouithys-Mickalad A; Deby-Dupont G; Dogné JM; Delarge J; Reginster JY Inflamm Res; 2001 Aug; 50(8):391-9. PubMed ID: 11556519 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]